Dr. Abdelmessieh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16 Emerald Road
Robbinsville, NJ 08691Phone+1 212-434-2000
Education & Training
- Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 2011 - 2014
- Touro University CaliforniaClass of 2011
Certifications & Licensure
- DE State License 2018 - 2025
- NJ State License 2023 - 2025
- PA State License 2014 - 2024
- NY State License 2017 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss
Journal of the National Comprehensive Cancer Network. 2024-10-01 - 1 citationsNCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, Haris Ali, Mariana Castells
Journal of the National Comprehensive Cancer Network. 2024-06-01 - Acute myeloid leukemia with a novelfusion transformed from essential thrombocythemia: A case report and mini review.Yavuz Sahin, Jianming Pei, Don A Baldwin, Nashwa Mansoor, Lori Koslosky
Leukemia Research Reports. 2024-01-01
Press Mentions
- Targeted Agent Improves Survival in FLT3-Positive Acute Myeloid LeukemiaDecember 17th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: